Evidence map›Paper›PMID 9724778›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

A cis-acting element that directs the activity of the murine methylation modifier locus Ssm1.

P Engler, L T Doglio, G Bozek, U Storb

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P EnglerDepartment of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60637, USA. jpengler@midway.uchicago.edu
L T Doglio
G Bozek
U Storb
University of Chicago · US

Funding

CONTROL OF IMMUNOGLOBULIN SYNTHESISR37AI024780 · NIAID · UNIVERSITY OF CHICAGO · PI STORB, URSULA B · 1992 to 2001
$430k
CONTROL OF IMMUNOGLOBULIN SYNTHESISR01AI024780 · NIAID · UNIVERSITY OF CHICAGO · PI STORB, URSULA B · 1986 to 1990
–
NIAID NIH HHS AI 24780
6 · The paper itself

Abstract

Silencing of chromosomal domains has been described in diverse systems such as position effect variegation in insects, silencing near yeast telomeres, and mammalian X chromosome inactivation. In mammals, silencing is associated with methylation at CpG dinucleotides, but little is known about how methylation patterns are established or altered during development. We previously described a strain-specific modifier locus, Ssm1, that controls the methylation of a complex transgene. In this study we address the questions of the nature of Ssm1's targets and whether its effect extends into adjacent sequences. By examining the inheritance of methylation patterns in a series of mice harboring deletion derivatives of the original transgene, we have identified a discrete segment, derived from the gpt gene of Escherichia coli, that is a major determinant for Ssm1-mediated methylation. Methylation analysis of sequences adjacent to a transgenic target indicates that the influence of this modifier extends into the surrounding chromosome in a strain-dependent fashion. Implications for the mechanism of Ssm1 action are discussed.

Indexed as

Saccharomyces cerevisiae ProteinsAnimalsChromosome MappingDNA MethylationFemaleFungal ProteinsGene DeletionMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicPedigreeRibosomal ProteinsTransgenesFungal ProteinsRibosomal ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID9724778
PMCPMC27969
OpenAlexW2132803435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.